Gilles R. Dagenais

Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease

Jean‐Pierre Després, Benoı̂t Lamarche, Pascale Mauriège et al. · New England Journal of Medicine · 1996 · 1.7K citations · Full text

Medicine, Cardiology, Endocrinology +11

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Salim Yusuf, Shofiqul Islam, Clara K Chow et al. · The Lancet · 2011 · 981 citations

Medicine, Cardiology, Surgery +10

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Martin St. John Sutton, Marc A. Pfeffer, Theodore Plappert et al. · Circulation · 1994 · 819 citations

Medicine, Cardiology, Pharmacotherapy +17

Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men

Isabelle Lemieux, Benoı̂t Lamarche, Charles Couillard et al. · Archives of Internal Medicine · 2001 · 489 citations

Medicine, Cardiology, Clinical Cardiology +16